Phospho-ERK was highly expressed in both mouse and human AD skin, and topical application of an ERK inhibitor alleviated clinical symptoms, histological alterations, increased TEWL, and the decreased expression of filaggrin in the AD-like NC/Nga murine model [38]. The gene discussed is FLG; the disease is Alzheimer disease.